Centre Hospitalier Universitaire Rouen

Research site

France 147 Avenue Du Marechal Juin, 76230 Bois-Guillaume, France

11 trials recruiting
Chronic kidney disease · Kidney transplant rejection · Hypertension
Adults and children

About Specializations

Centre Hospitalier Universitaire Rouen in Bois-Guillaume, France specialises in clinical trials of conditions such as Chronic kidney disease, Kidney transplant rejection, Hypertension, Obesity, and other specialisations. This site conducts important research.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

147 Avenue Du Marechal Juin76230 Bois-GuillaumeFrance

Open in maps ↗

Recruiting now: 11 trials
Conditions studied: 17

More sites in Bois-Guillaume France

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

22 clinical trials

Chronic kidney disease+1

Recruiting

Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

Registered drug

Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Baxdrostat
Sponsor:AstraZeneca AB

Contact Research Centre

Obesity

Recruiting

RO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes

Investigational

RO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes

Investigational

France

Participants:18–64 years · 65+ years
Sponsor:F. Hoffmann-La Roche AG

Contact Research Centre

Chronic kidney disease+1

Recruiting

A study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease

Investigational

A study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease

Investigational

France

Participants:18–64 years · 65+ years
Sponsor:Eli Lilly & Co.

Contact Research Centre

Viral infection

Recruiting

Study on Early Stopping of Antibiotics in Elderly Patients with Viral Infections Using Amoxicillin, Clavulanic Acid, Piperacillin, Tazobactam, and Pristinamycin

Registered drugNo placebo

Study on Early Stopping of Antibiotics in Elderly Patients with Viral Infections Using Amoxicillin, Clavulanic Acid, Piperacillin, Tazobactam, and Pristinamycin

Registered drugNo placebo

France

Participants:65+ years
Substances:Amoxicillin Sodium
Sponsor:Centre Hospitalier Universitaire Amiens Picardie

Contact Research Centre

Pneumothorax

Recruiting

Study on the Effects of Ketoprofen and Drug Combination in Patients Undergoing Pleurodesis Surgery for Pneumothorax

Registered drug

Study on the Effects of Ketoprofen and Drug Combination in Patients Undergoing Pleurodesis Surgery for Pneumothorax

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Ketoprofen
Sponsor:Centre Hospitalier Universitaire Amiens Picardie

Contact Research Centre

Hypoxic ischaemic encephalopathy neonatal

Recruiting

Study of Autologous Cord Blood Stem Cells Treatment for Newborns with Hypoxic-Ischemic Encephalopathy

InvestigationalNo placebo

Study of Autologous Cord Blood Stem Cells Treatment for Newborns with Hypoxic-Ischemic Encephalopathy

InvestigationalNo placebo

France

Participants:0–17 years
Substances:Autologous Cord Blood-Derived Mononuclear Cells
Sponsor:Centre Hospitalier Regional De Marseille

Contact Research Centre

Atypical haemolytic uraemic syndrome

Recruiting

Study of Eculizumab in Adults with Hypertensive Emergency-Related Hemolytic Uremic Syndrome Requiring Dialysis or with Severe Kidney Problems

Registered drugNo placebo

Study of Eculizumab in Adults with Hypertensive Emergency-Related Hemolytic Uremic Syndrome Requiring Dialysis or with Severe Kidney Problems

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Eculizumab
Sponsor:Assistance Publique Hopitaux De Paris

Contact Research Centre

Atypical haemolytic uraemic syndrome

Recruiting

Study on Switching from Anti-C5 Antibody Therapy to Iptacopan for Patients with Atypical Hemolytic Uremic Syndrome (aHUS)

InvestigationalNo placebo

Study on Switching from Anti-C5 Antibody Therapy to Iptacopan for Patients with Atypical Hemolytic Uremic Syndrome (aHUS)

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Iptacopan
Sponsor:Novartis Pharma AG

Contact Research Centre

Procedural pain

Recruiting

Study on the Effect of Ketoprofen and Drug Combination for Managing Pain After Heart Surgery in Patients

Registered drug

Study on the Effect of Ketoprofen and Drug Combination for Managing Pain After Heart Surgery in Patients

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Ketoprofen
Sponsor:Centre Hospitalier Universitaire Amiens Picardie

Contact Research Centre

Cytomegalovirus infection

Recruiting

Study on Letermovir and Valganciclovir for Treating CMV Infections in Kidney Transplant Patients

Registered drug

Study on Letermovir and Valganciclovir for Treating CMV Infections in Kidney Transplant Patients

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Letermovir
Sponsor:Assistance Publique Hopitaux De Paris

Contact Research Centre

Anti-neutrophil cytoplasmic antibody positive vasculitis

Recruiting

Study on Pioglitazone for Improving Kidney Health in Patients with ANCA-Associated Vasculitis

Registered drug

Study on Pioglitazone for Improving Kidney Health in Patients with ANCA-Associated Vasculitis

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Dexchlorpheniramine
Sponsor:Assistance Publique Hopitaux De Paris

Contact Research Centre

Anti-neutrophil cytoplasmic antibody positive vasculitis

Not yet recruiting

Testing avacopan added to standard treatment in patients with ANCA-associated vasculitis with severe kidney damage

Registered drug

Testing avacopan added to standard treatment in patients with ANCA-associated vasculitis with severe kidney damage

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Avacopan
Sponsor:Centre Hospitalier Universitaire De Toulouse

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites